(EMERYVILLE, Calif.)Onyx Pharmaceuticals Inc. and Bayer AG said Friday that liver cancer patients treated their drug candidate Nexavar lived longer than those who received a placebo in a clinical tria...READ MORE

(NEW YORK)Onyx Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. said Thursday they are enrolling patients in a late stage trial of their drug Nexavar as a post-surgery treatmen...READ MORE

(NEW YORK)Partners Onyx Pharmaceuticals and Bayer said Monday China's drug regulatory agency approved the liver cancer treatment Nexavar, opening the door to one of the largest markets for t...READ MORE

(NEW YORK)Onyx Pharmaceuticals Inc. said Gregory W. Schafer has resigned as chief financial officer, effective Dec. 15 or earlier if the company finds a replacement.READ MORE

(NEW YORK)Sales of the cancer drug Nexavar will push Onyxx Pharmaceuticals to a 2008 profit, according to a Lehman Brothers analyst, who said the global opportunity for the drug has been und...READ MORE